Searching for the Autoimmune Thyroid Disease Susceptibility Genes: From Gene Mapping to Gene Function

Endocrine Reviews

Volumn 24, Issue 5, 2003, Pages 694-717

  Tomer, Yaron ^a,b   Davies, Terry F ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; IODINE; MICROSATELLITE DNA; THYROID ANTIGEN; UNCLASSIFIED DRUG;

ALGORITHM; AUTOIMMUNE DISEASE; AUTOIMMUNE THYROID DISEASE; CANDIDATE GENE ANALYSIS; CHROMOSOME 14Q; CHROMOSOME 20Q; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4 COSTIMULATORY MOLECULE GENE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4 GENE; DIETARY INTAKE; DISEASE SEVERITY; ENVIRONMENTAL FACTOR; EPIDEMIOLOGICAL DATA; FAMILIAL DISEASE; FAMILY STUDY; GENE; GENE FUNCTION; GENE INTERACTION; GENE LOCUS; GENE MAPPING; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; GENOME; GENOME SCREENING; GRAVES DISEASE; HASHIMOTO DISEASE; HEREDITY; HLA SYSTEM; HUMAN; HUMAN LEUKOCYTE ANTIGEN GENE; IMMUNE MODIFYING GENE; INSULIN DEPENDENT DIABETES MELLITUS; LINKAGE ANALYSIS; MOLECULAR MECHANICS; PHENOTYPE; POPULATION RESEARCH; PRIORITY JOURNAL; REVIEW; SEGREGATION ANALYSIS; SIBLING; SINGLE NUCLEOTIDE POLYMORPHISM; T LYMPHOCYTE RECEPTOR GENE; THYROGLOBULIN GENE; THYROID DISEASE; THYROID PEROXIDASE GENE; THYROID SPECIFIC GENE; THYROTROPIN RECEPTOR GENE; TWINS; WHOLE GENOME SCREEN; X CHROMOSOME;

ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; AUTOIMMUNE DISEASES; CHROMOSOME MAPPING; FAMILY; GENETIC PREDISPOSITION TO DISEASE; HLA ANTIGENS; HUMANS; LINKAGE (GENETICS); SIBLINGS; THYROID DISEASES; TWIN STUDIES;

EID: 0141801751     PISSN: 0163769X     EISSN: None     Source Type: Journal    
DOI: 10.1210/er.2002-0030     Document Type: Review

References (308)

1. Davies TF 2000 Graves' diseases: pathogenesis. In: Braverman LE, Utiger RD, eds. Werner and Ingbar's the thyroid: a fundamental and clinical text. Philadelphia: Lippincott Williams & Wilkens; 518-530
2. Weetman AP 1996 Chronic autoimmune thyroiditis. In: Braverman LE, Utiger RD, eds. Werner and Ingbar's the thyroid. Philadelphia: Lippincott-Raven; 738-748
3. Stagnaro-Green A 2002 Clinical review 152: postpartum thyroiditis. J Clin Endocrinol Metab 87:4042-4047
4. Roti E, Uberti E 2002 Post-partum thyroiditis - a clinical update. Eur J Endocrinol 146:275-279
5. Muller AF, Drexhage HA, Berghout A 2001 Postpartum thyroiditis and autoimmune thyroiditis in women of childbearing age: recent insights and consequences for antenatal and postnatal care. Endocr Rev 22:605-630
6. Martino E, Bartalena L, Bogazzi F, Braverman LE 2001 The effects of amiodarone on the thyroid. Endocr Rev 22:240-254
7. Marazuela M, Garcia-Buey L, Gonzalez-Fernandez B, Garcia-Monzon C, Arranz A, Borque MJ, Moreno-Otero R 1996 Thyroid autoimmune disorders in patients with chronic hepatitis C before and during interferon-α therapy. Clin Endocrinol (Oxf) 44:635-642
8. Dumoulin FL, Leifeld L, Sauerbruch T, Spengler U 1999 Autoimmunity induced by interferon-α therapy for chronic viral hepatitis. Biomed Pharmacother 53:242-254
9. Obermayer-Straub P, Manns MP 1998 Autoimmune polyglandular syndromes. Baillieres Clin Gastroenterol 12:293-315
10. Betterle C, Volpato M, Greggio AN, Presotto F 1996 Type 2 polyglandular autoimmune disease (Schmidt's syndrome). J Pediatr Endocrinol Metab 9(Suppl 1):113-123
11. Hall R, Dingle PR, Roberts DF 1972 Thyroid antibodies: a study of first degree relatives. Clin Genet 3:319-324
12. Brix TH, Kyvik KO, Hegedus L 1998 What is the evidence of genetic factors in the etiology of Graves' disease? A brief review. Thyroid 8:727-734
13. Tomer Y, Barbesino G, Greenberg DA, Davies TF 1997 The immunogenetics of autoimmune diabetes and autoimmune thyroid disease. Trends Endocrinol Metab 8:63-70
14. Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, Braverman LE 2002 Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 87:489-499
15. Canaris GJ, Manowitz NR, Mayor G, Ridgway EC 2000 The Colorado thyroid disease prevalence study. Arch Intern Med 160: 526-534
16. Tunbridge WMG, Evered DC, Hall R, Appleton D, Brewis M, Clark F, Evans JG, Young E, Bird T, Smith PA 1977 The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf) 7:481-493
17. Phillips DI, Barker DJ, Rees Smith B, Didcote S, Morgan D 1985 The geographical distribution of thyrotoxicosis in England according to the presence or absence of TSH-receptor antibodies. Clin Endocrinol (Oxf) 23:283-287
18. Brownlie BE, Welsh JD 1990 The epidemiology of thyrotoxicosis in New Zealand: incidence and geographical distribution in north Canterbury, 1983-1985. Clin Endocrinol (Oxf) 33:249-259
19. Berglund J, Christensen SB, Hallengren B 1990 Total and age-specific incidence of Graves' thyrotoxicosis, toxic nodular goitre and solitary toxic adenoma in Malmo 1970-74. J Intern Med 227: 137-141
20. Laurberg P, Pedersen KM, Vestergaard H, Sigurdsson G 1991 High incidence of multinodular toxic goitre in the elderly population in a low iodine intake area vs. high incidence of Graves' disease in the young in a high iodine intake area: comparative surveys of thyrotoxicosis epidemiology in East-Jutland Denmark and Iceland. J Intern Med 229:415-420
21. Bulow Pedersen I, Knudsen N, Jorgensen T, Perrild H, Ovesen L, Laurberg P 2002 Large differences in incidences of overt hyper-and hypothyroidism associated with a small difference in iodine intake: a prospective comparative register-based population survey. J Clin Endocrinol Metab 87:4462-4469
22. Haraldsson A, Gudmundsson ST, Larusson G, Sigurdsson G 1985 Thyrotoxicosis in Iceland 1980-1982. An epidemiological survey. Acta Med Scand 217:253-258
23. Furszyfer J, Kurland LT, McConahey WM, Elveback LR 1970 Graves' disease in Olmsted County, Minnesota, 1935 through 1967. Mayo Clin Proc 45:636-644
24. Mogensen EF, Green A 1980 The epidemiology of thyrotoxicosis in Denmark. Incidence and geographical variation in the Funen region 1972-1974. Acta Med Scand 208:183-186
25. Gordin A, Heinonen OP, Saarinen P, Lamberg BA 1972 Serum thyrotrophin in symptomless autoimmune thyroiditis. Lancet 1:551-554
26. Okamura K, Ueda K, Sone H, Ikenoue H, Hasuo Y, Sato K, Yoshinari M, Fujishima M 1989 A sensitive thyroid stimulating hormone assay for screening of thyroid functional disorder in elderly Japanese. J Am Geriatr Soc 37:317-322
27. Jacobson DL, Gange SJ, Rose NR, Graham NM 1997 Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol 84: 223-243
28. Sawin CT, Castelli WP, Hershman JM, McNamara P, Bacharach P 1985 The aging thyroid. Thyroid deficiency in the Framingham Study. Arch Intern Med 145:1386-1388
29. Furszyfer J, Kurland LT, McConahey WM, Woolner LB, Elveback LR 1972 Epidemiologic aspects of Hashimoto's thyroiditis and Graves' disease in Rochester, Minnesota (1935-1967), with special reference to temporal trends. Metabolism 21:197-204
30. Berglund J, Ericsson UB, Hallengren B 1996 Increased incidence of thyrotoxicosis in Malmo during the years 1988-1990 as compared to the years 1970-1974. J Intern Med 239:57-62
31. Davies TF, Amino N 1993 A new classification for human autoimmune thyroid disease. Thyroid 3:331-333
32. Bartels ED 1941 Twin examinations: heredity in Graves' disease. Copenhagen: Munksgaard; 32-36
33. Martin L 1945 The heredity and familial aspects of exophathalmic goitre and nodular goitre. Q J Med 14:207-219
34. Hall R, Stanbury JB 1967 Familial studies of autoimmune thyroiditis. Clin Exp Immunol 2:719-725
35. Tamai H, Ohsako N, Takeno K, Fukino O, Takahashi H, Kuma K, Kumagai LF, Nagataki S 1980 Changes in thyroid function in euthyroid subjects with family history of Graves' disease; a follow-up study of 69 patients. J Clin Endocrinol Metab 51:1123-1128
36. Chopra IJ, Solomon DH, Chopra U, Yodhihara E, Tersaki PL, Smith F 1977 Abnormalities in thyroid function in relatives of patients with Graves' disease and Hashimoto's thyroiditis: lack of correlation with inheritance of HLA-B8. J Clin Endocrinol Metab 45:45-54
37. Tamai H, Kumagai LF, Nagataki S 1986 Immunogenetics of Graves' disease. In: McGregor AM, ed. Immunology of endocrine diseases. Lancaster, UK: MTP Press; 123-141
38. Carey C, Skosey C, Pinnamaneni KM, Barsano CP, DeGroot LJ 1980 Thyroid abnormalities in children of parents who have Graves' disease: possible pre-Graves' disease. Metabolism 29: 369-376
39. Volpe R 1985 Autoimmune thyroid disease. In: Volpe R, ed. Autoimmunity and endocrine disease. New York: Marcel Dekker; 109-285
40. Burek CL, Hoffman WH, Rose NR 1982 The presence of thyroid autoantibodies in children and adolescents with AITD and in their siblings and parents. Clin Immunol Immunopathol 25:395-404
41. Villanueva RB, Inzerillo AM, Tomer Y, Barbesino G, Meltzer M, Concepcion ES, Greenberg DA, Maclaren N, Sun ZS, Zhang DM, Tucci S, Davies TF 2000 Limited genetic susceptibility to severe Graves' ophthalmopathy: no role for CTLA-4 and evidence for an environmental etiology. Thyroid 10:791-798
42. Tomer Y, Davies TF 1993 Infection, thyroid disease and autoimmunity. Endocr Rev 14:107-120
43. Williams D 1996 Thyroid cancer and the Chernobyl accident. J Clin Endocrinol Metab 81:6-8
44. Risch N 1990 Linkage strategies for genetically complex traits. II. The power of affected relative pairs. Am J Hum Genet 46:229-241
45. Villanueva R, Greenberg DA, Davies TF, Tomer Y 2003 Sibling recurrence risk in autoimmune thyroid disease. Thyroid 13:761-764
46. Allahabadia A, Gough SC 1999 The different approaches to the genetic analysis of autoimmune thyroid disease. J Endocrinol 163: 7-13
47. Pauls DL, Zakarija M, McKenzie JM, Egeland JA 1993 Complex segregation analysis of antibodies to thyroid peroxidase in Old Order Amish families. Am J Med Genet 47:375-379
48. Phillips D, McLachlan S, Stephenson A, Roberts D, Moffitt S, McDonald D, Ad'Hiah A, Stratton A, Young E, Clark F 1990 Autosomal dominant transmission of autoantibodies to thyroglobulin and thyroid peroxidase. J Clin Endocrinol Metab 70:742-746
49. Phillips DIW, Prentice L, McLachlan SM, Upadhyaya M, Lunt PW, Rees Smith B 1991 Autosomal dominant inheritance of the tendency to develop thyroid autoantibodies. Exp Clin Endocrinol 97:170-172
50. Jaume JC, Guo J, Pauls DL, Zakarija M, McKenzie JM, Egeland JA, Burek CL, Rose NR, Hoffman WH, Rapoport B, McLachlan SM 1999 Evidence for genetic transmission of thyroid peroxidase autoantibody epitopic "fingerprints. " J Clin Endocrinol Metab 84: 1424-1431
51. Hall JG 1996 Twinning: mechanisms and genetic implications. Curr Opin Genet Dev 6:343-347
52. Monteiro J, Hingorani R, Choi I-H, Silver J, Pergolizzi R, Gregersen PK 1995 Oligoclonality in the human CD8+ T cell repertoire in normal subjects and twins: implications for studies of infectious and autoimmune diseases. Mol Med 1:614-624
53. Brix TH, Christensen K, Holm NV, Harvald B, Hegedus L 1998 A population-based study of Graves' diseases in Danish twins. Clin Endocrinol (Oxf) 48:397-400
54. Brix TH, Kyvik KO, Christensen K, Hegedus L 2001 Evidence for a major role of heredity in Graves' disease: a population-based study of two Danish twin cohorts. J Clin Endocrinol Metab 86: 930-934
55. Ringold DA, Nicoloff JT, Kesler M, Davis H, Hamilton A, Mack T 2002 Further evidence for a strong genetic influence on the development of autoimmune thyroid disease: the California twin study. Thyroid 12:647-653
56. Brix TH, Kyvik KO, Hegedus L 2000 A population-based study of chronic autoimmune hypothyroidism in Danish twins. J Clin Endocrinol Metab 85:536-539
57. Phillips DI, Osmond C, Baird J, Huckle A, Rees-Smith B 2002 Is birthweight associated with thyroid autoimmunity? A study in twins. Thyroid 12:377-380
58. Everett LA, Glaser B, Beck JC, Idol JR, Buchs A, Heyman M, Adawi F, Hazani E, Nassir E, Baxevanis AD, Sheffield VC, Green ED 1997 Pendred syndrome is caused by mutations in a putative sulphate transporter gene (PDS). Nat Genet 17:411-422
59. Davies JL, Kawauchi Y, Bennet ST, Copeman JB, Cordell HJ, Pritchard LE, Reed PW, Gough SCL, Jenkins SC, Palmer SM, Balfour KM, Rowe BR, Farrall M, Barnett AH, Baln SC, Todd JA 1994 A genome-wide search for human type 1 diabetes susceptibility genes. Nature 371:130-136
60. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J, Almer S, Tysk C, O'Morain CA, Gassull M, Binder V, Finkel Y, Cortot A, Modigliani R, Laurent-Puig P, Gower-Rousseau C, Macry J, Colombel J-F, Sahbatou M, Thomas G 2001 Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411:599-603
61. Greenberg DA 1993 Linkage analysis of "necessary" loci vs. "susceptibility" loci. Am J Hum Genet 52:135-143
62. Ott J 1996 Analysis of human genetic linkage. Baltimore: Johns Hopkins University Press
63. Greenberg DA, Abreu PC 2001 Determining trait locus position from multipoint analysis: accuracy and power of three different statistics. Genet Epidemiol 21:299-314
64. Terwilliger JD, Zollner S, Laan M, Paabo S 1998 Mapping genes through the use of linkage disequilibrium generated by genetic drift: 'drift mapping' in small populations with no demographic expansion. Hum Hered 48:138-154
65. Hodge SE, Anderson CE, Neiswanger K, Sparkes RS, Rimoin DL 1983 The search for heterogeneity in insulin dependent diabetes mellitus (IDDM): linkage studies, two-locus models, and genetic heterogeneity. Am J Hum Genet 35:1139-1155
66. Lander E, Kruglyak L 1995 Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 11:241-247
67. Pal DK, Greenberg DA 2002 Evaluating genetic heterogeneity in complex disorders. Hum Hered 53:216-226
68. Ott J 1977 Counting methods (EM algorithm) in human pedigree analysis: linkage and segregation analysis. Ann Hum Genet 40: 443-454
69. Risch N, Baron M 1982 X-linkage and genetic heterogeneity in bipolar-related major affective illness: reanalysis of linkage data. Ann Hum Genet 46:153-166
70. Kruglyak L, Daly MJ, Reeve-Daly MP, Lander ES 1996 Parametric and nonparametric linkage analysis: a unified multipoint approach. Am J Hum Genet 58:1347-1363
71. Risch N, Merikangas K 1996 The future of genetic studies of complex human diseases. Science 273:1516-1517
72. Sham P, Bader JS, Craig I, O'Donovan M, Owen M 2002 DNA pooling: a tool for large-scale association studies. Nat Rev Genet 3:862-871
73. Woolf B 1955 On estimating the relation between blood group and disease. Ann Hum Genet 19:251-253
74. Hodge SE 1994 What association analysis can and cannot tell us about the genetics of complex disease. Am J Med Genet 54:318-323
75. Spielman RS, McGinnis RE, Ewens WJ 1993 Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus. Am J Hum Genet 52:506-516
76. Falk CT, Rubinstein P 1987 Haplotype relative risks: an easy and reliable way to construct a proper control sample for risk calculations. Ann Hum Genet 51:227-233
77. Schaid DJ, Sommer SS 1994 Comparison of statistics for candidate-gene association studies using cases and parents. Am J Hum Genet 55:402-409
78. Greenberg DA, Berger B 1994 Using LOD score differences to determine mode of inheritance: simple, robust method even in the presence of heterogeneity and reduced penetrance. Am J Hum Genet 55:834-840
79. Tomer Y, Barbesino G, Greenberg DA, Concepcion ES, Davies TF 1998 A new Graves' disease-susceptibility locus maps to chromosome 20q11.2. Am J Hum Genet 63:1749-1756
80. Froguel P, Zouali H, Vionnet N, Velho G, Vaxillaire M, Pharm D, Sun F, Lesage S, Stoffel M, Takeda J, Passa P, Permutt MA, Beckmann J, Bell GI, Cohen D 1993 Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus. N Engl J Med 328:697-702
81. Weber JL 1990 Human DNA polymorphisms based on length variations in simple-sequence tandem repeats. In: Tilghman S, Davies K, eds. Genome analysis, Vol 1. Genetic and physical mapping. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 159-181
82. Brookes AJ 1999 The essence of SNPs. Gene 234:177-186
83. Laan M, Paabo S 1998 Mapping genes by drift-generated linkage disequilibrium. Am J Hum Genet 63:654-656
84. Ogura Y, Bonen DK, Inohara N, Nicolase DL, Chen FF, Ramos R, Britton H, Moran T, Karaliuskas R, Duerr RH, Achkar J-P, Brant SR, Bayless TM, Kirschner BS, Hanauer SB, Nuñez G, Cho JH 2001 A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411:603-606
85. Morahan G, Huang D, Ymer SI, Cancilla MR, Stephen K, Dabadghao P, Werther G, Tait BD, Harrison LC, Colman PG 2001 Linkage disequilibrium of a type 1 diabetes susceptibility locus with a regulatory IL12B allele. Nat Genet 27:218-221
86. Campbell RD, Trowsdale J 1993 Map of the human MHC. Immunol Today 14:349-352
87. Nelson JL, Hansen JA 1990 Autoimmune disease and HLA. CRC Crit Rev Immunol 10:307-328
88. Bech K, Lumholtz B, Nerup J, Thomsen M, Platz P, Ryder LP, Svejgaard A, Siersbaek-Nielsen K, Hansen JM, Larse JH 1977 HLA antigens in Graves' disease. Acta Endocrinol (Copenh) 86: 510-516
89. Farid NR, Stone E, Johnson G 1980 Graves' disease and HLA: clinical and epidemiologic associations. Clin Endocrinol (Oxf) 13: 535-544
90. Farid NR 1981 Graves' disease. In: Farid NR, ed. HLA in endocrine and metabolic disorders. New York: Academic Press; 85-143
91. Farid NR, Sampson L, Noel EP, Barnard JM, Mandeville R, Larsen B, Marshall WH, Carter ND 1979 A study of human D locus related antigens in Graves' disease. J Clin Invest 63:108-113
92. Mangklabruks A, Cox N, DeGroot LJ 1991 Genetic factors in autoimmune thyroid disease analyzed by restriction fragment length polymorphisms of candidate genes. J Clin Endocrinol Metab 73:236-244
93. Volpe R 1990 Immunology of human thyroid disease. In: Volpe R, ed. Autoimmunity in endocrine disease. Boca Raton, FL: CRC Press; 73
94. Heward JM, Allahabadia A, Daykin J, Carr-Smith J, Daly A, Armitage M, Dodson PM, Sheppard MC, Barnett AH, Franklyn JA, Gough SC 1998 Linkage disequilibrium between the human leukocyte antigen class II region of the major histocompatibility complex and Graves' disease: replication using a population case control and family-based study. J Clin Endocrinol Metab 83:3394-3397
95. Kawa A, Nakamura S, Nakazawa M, Sakaguch S, Kawabata T, Maeda Y, Kanehisa T 1977 HLA-BW35 and B5 in Japanese patients with Graves' disease. Acta Endocrinol (Copenh) 86:754-757
96. Inoue D, Sato K, Enomoto T, Sugawa H, Maeda M, Inoko H, Tsuji K, Mori T, Imura H 1992 Correlation of HLA types and clinical findings in Japanese patients with hyperthyroid Graves' disease: evidence indicating the existence of four subpopulations. Clin Endocrinol (Oxf) 36:75-82
97. Onuma H, Ota M, Sugenoya A, Inoko H 1994 Association of HLA-DPB1*0501 with early-onset Graves' disease in Japanese. Hum Immunol 39:195-201
98. Katsuren E, Awata T, Matsumoto C, Yamamoto K 1994 HLA class II alleles in Japanese patients with Graves' disease: weak associations of HLA-DR and -DQ. Endocr J 41:599-603
99. Ohtsuka K, Nakamura Y 1998 Human leukocyte antigens associated with hyperthyroid Graves ophthalmology in Japanese patients. Am J Ophthalmol 126:805-810
100. Chan SH, Yeo PP, Lui KF, Wee GB, Woo KT, Lim P, Cheah JS 1978 HLA and thyrotoxicosis (Graves' disease) in Chinese. Tissue Antigens 12:109-114
101. Cavan DA, Penny MA, Jacobs KH, Kelly MA, Jenkins D, Mijovic C, Chow C, Cockram CS, Hawkins BR, Barnett AH 1994 The HLA association with Graves' disease is sex-specific in Hong Kong Chinese subjects. Clin Endocrinol (Oxf) 40:63-66
102. Chan SH, Lin YN, Wee GB, Ren EC, Lui KF, Cheah JS 1993 Human leucocyte antigen DNA typing in Singaporean Chinese patients with Graves' disease. Ann Acad Med Singapore 22:576-579
103. Tan S, Chan S, Lee B, Wee G, Wong H 1988 HLA association in Singapore children with Grave's disease. Metabolism 37:518-519
104. Yeo PP, Chan SH, Thai AC, Ng WY, Lui KF, Wee GB, Tan SH, Lee BW, Wong HB, Cheah JS 1989 HLA Bw46 and DR9 associations in Graves' disease of Chinese patients are age-and sex-related. Tissue Antigens 34:179-184
105. Glazier AM, Nadeau JH, Aitman TJ 2002 Finding genes that underlie complex traits. Science 298:2345-2349
106. Maciel LM, Rodrigues SS, Dibbern RS, Navarro PA, Donadi EA 2001 Association of the HLA-DRB1*0301 and HLA-DQA1*0501 alleles with Graves' disease in a population representing the gene contribution from several ethnic backgrounds. Thyroid 11:31-35
107. Barlow ABT, Wheatcroft N, Watson P, Weetman AP 1996 Association of HLA-DQA1*0501 with Graves' disease in English Caucasian men and women. Clin Endocrinol (Oxf) 44:73-77
108. Yanagawa T, Mangklabruks A, Chang YB, Okamoto Y, Fisfalen M-E, Curran PG, DeGroot LJ 1993 Human histocompatibility leukocyte antigen-DQA1*0501 allele associated with genetic susceptibility to Graves' disease in a Caucasian population. J Clin Endocrinol Metab 76:1569-1574
109. Marga M, Denisova A, Sochnev A, Pirags V, Farid NR 2001 Two HLA DRB 1 alleles confer independent genetic susceptibility to Graves disease: relevance of cross-population studies. Am J Med Genet 102:188-191
110. Zamani M, Spaepen M, Bex M, Bouillon R, Cassiman JJ 2000 Primary role of the HLA class II DRB1*0301 allele in Graves disease. Am J Med Genet 95:432-437
111. Marsh SG, Bodmer JG, Albert ED, Bodmer WF, Bontrop RE, Dupont B, Erlich HA, Hansen JA, Mach B, Mayr WR, Parham P, Petersdorf EW, Sasazuki T, Schreuder GM, Strominger JL, Svejgaard A, Terasaki PI 2001 Nomenclature for factors of the HLA system, 2000. Hum Immunol 62:419-468
112. Ban Y, Davies TF, Greenberg DA, Concepcion ES, Tomer Y, Potential role of HLA-DR-74 arginine in the genetic susceptibility to Graves' disease. Program of the 84th Annual Meeting of The Endocrine Society, San Francisco, CA, 2002, p 95 (Abstract OR22-5)
113. Segni M, Pani MA, Pasquino AM, Badenhoop K 2002 Familial clustering of juvenile thyroid autoimmunity: higher risk is conferred by human leukocyte antigen DR3-DQ2 and thyroid peroxidase antibody status in fathers. J Clin Endocrinol Metab 87:3779-3782
114. Schleusener H, Schwander J, Fischer C, Holle R, Holl G, Badenhoop K, Hensen J, Finke R, Bogner U, Mayr WR 1989 Prospective multicentre study on the prediction of relapse after antithyroid drug treatment in patients with Graves' disease. Acta Endocrinol (Copenh) 120:689-701
115. Dahlberg PA, Holmlund G, Karlsson FA, Safwenberg J 1981 HLA-A, -B, -C and -DR antigens in patients with Graves' disease and their correlation with signs and clinical course. Acta Endocrinol (Copenh) 97:42-47
116. McKenna R, Kearns M, Sugrue D, Drury MI, McCarthy CF 1982 HLA and hyperthyroidism in Ireland. Tissue Antigens 19:97-99
117. Allannic H, Fauchet R, Lorcy Y, Gueguen M, Le Guerrier AM, Genetet B 1983 A prospective study of the relationship between relapse of hyperthyroid Graves' disease after antithyroid drugs and HLA haplotype. J Clin Endocrinol Metab 57:719-722
118. Kendall-Taylor P, Stephenson A, Stratton A, Papiha SS, Perros P, Roberts DF 1988 Differentiation of autoimmune ophthalmopathy from Graves' hyperthyroidism by analysis of genetic markers. Clin Endocrinol (Oxf) 28:601-610
119. Rapoport B, Alsabeh R, Aftergood D, McLachlan SM 2000 Elephantiasic pretibial myxedema: insight into and a hypothesis regarding the pathogenesis of the extrathyroidal manifestations of Graves' disease. Thyroid 10:685-692
120. Irvine WJ, Gray RS, Morris PJ, Ting A 1978 HLA in primary atrophic hypothyroidism and Hashimoto goitre. J Clin Lab Immunol 3:193-195
121. Farid NR, Sampson L, Moens H, Barnard JM 1981 The association of goitrous autoimmune thyroiditis with HLA-DR5. Tissue Antigens 17:265-268
122. Moens H, Farid NR, Sampson L, Noel EP, Barnard JM 1978 Hashimoto's thyroiditis is associated with HLA-DRw3. N Engl J Med 299:133-134
123. Tandon N, Zhang L, Weetman AP 1991 HLA associations with Hashimoto's thyroiditis. Clin Endocrinol (Oxf) 34:383-386
124. Ban Y, Davies TF, Greenberg DA, Concepcion ES, Tomer Y 2002 The influence of human leucocyte antigen (HLA) genes on autoimmune thyroid disease (AITD): results of studies in HLA-DR3 positive AITD families. Clin Endocrinol (Oxf) 57:81-88
125. Kong YC, Lomo LC, Motte RW, Giraldo AA, Baisch J, Strauss G, Hammerling GJ, David CS 1996 HLA-DRB1 polymorphism determines susceptibility to autoimmune thyroiditis in transgenic mice: definitive association with HLA-DRB1*0301 (DR3) gene. J Exp Med 184:1167-1172
126. Wu Z, Stephens HAF, Sachs JA, Biro PA, Cutbush S, Magzoub MM, Becker C, Schwartz G, Botazzo GF 1994 Molecular analysis of HLA-DQ and -DP genes in caucasoid patients with Hashimoto's thyroiditis. Tissue Antigens 43:116-119
127. Badenhoop K, Schwartz G, Walfish PG, Drummond V, Usadel KH, Bottazzo GF 1990 Susceptibility to thyroid autoimmune disease: molecular analysis of HLA-D region genes identifies new markers for goitrous Hashimoto's thyroiditis. J Clin Endocrinol Metab 71:1131-1137
128. Honda K, Tamai H, Morita T, Kuma K, Nishimura Y, Sasazuki T 1989 Hashimoto's thyroiditis and HLA in Japanese. J Clin Endocrinol Metab 69:1268-1273
129. Hawkins BR, Lam KSL, Ma JTC, Wang C, Yeung RTT 1987 Strong association between HLA-DRw9 and Hashimoto's thyroiditis in Southern Chinese. Acta Endocrinol (Copenh) 114:543-546
130. Bode HH, Dorf ME, Forbes AP 1973 Familial lymphocytic thyroiditis: analysis of linkage with histocompatibility and blood group. J Clin Endocrinol Metab 37:692-697
131. Roman SH, Greenberg DA, Rubinstein P, Wallenstein S, Davies TF 1992 Genetics of autoimmune thyroid disease: lack of evidence for linkage to HLA within families. J Clin Endocrinol Metab 74: 496-503
132. Hawkins BR, Ma JT, Lam KS, Wang CC, Yeung RT 1985 Analysis of linkage between HLA haplotype and susceptibility to Graves' disease in multiple-case Chinese families in Hong Kong. Acta Endocrinol (Copenh) 110:66-69
133. Barbesino G, Tomer Y, Concepcion ES, Davies TF, Greenberg DA 1998 Linkage analysis of candidate genes in autoimmune thyroid disease. I. Selected immunoregulatory genes. J Clin Endocrinol Metab 83:1580-1584
134. Sakai K, Shirasawa S, Ishikawa N, Ito K, Tamai H, Kuma K, Akamizu T, Tanimura M, Furugaki K, Yamamoto K, Sasazuki T 2001 Identification of susceptibility loci for autoimmune thyroid disease to 5q31-q33 and Hashimoto's thyroiditis to 8q23-q24 by multipoint affected sib-pair linkage analysis in Japanese. Hum Mol Genet 10:1379-1386
135. Vaidya B, Imrie H, Perros P, Young ET, Kelly WF, Carr D, Large DM, Toft AD, McCarthy MI, Kendall-Taylor P, Pearce SH 1999 The cytotoxic T lymphocyte antigen-4 is a major Graves' disease locus. Hum Mol Genet 8:1195-1199
136. Shields DC, Ratanachaiyavong S, McGregor AM, Collins A, Morton NE 1994 Combined segregation and linkage analysis of Graves' disease with a thyroid autoantibody diathesis. Am J Hum Genet 55:540-554
137. Reiser H, Stadecker MJ 1996 Costimulatory B7 molecules in the pathogenesis of infectious and autoimmune diseases. N Engl J Med 335:1369-1377
138. Yanagawa T, Hidaka Y, Guimaraes V, Soliman M, DeGroot LJ 1995 CTLA-4 gene polymorphism associated with Graves' disease in a Caucasian population. J Clin Endocrinol Metab 80:41-45
139. Nistico L, Buzzetti R, Pritchard LE, Van der Auwera B, Giovannini C, Bosi E, Larrad MT, Rios MS, Chow CC, Cockram CS, Jacobs K, Mijovic C, Bain SC, Barnett AH, Vandewalle CL, Schuit F, Gorus FK, Tosi R, Pozzilli P, Todd JA 1996 The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Hum Mol Genet 5:1075-1080
140. Donner H, Rau H, Walfish PG, Braun J, Siegmund T, Finke R, Herwig J, Usadel KH, Badenhoop K 1997 CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus. J Clin Endocrinol Metab 82:143-146
141. Kotsa K, Watson PF, Weetman AP 1997 A CTLA-4 gene polymorphism is associated with both Graves' disease and autoimmune hypothyroidism. Clin Endocrinol (Oxf) 46:551-554
142. Kouki T, Gardine CA, Yanagawa T, DeGroot LJ 2002 Relation of three polymorphisms of the CTLA-4 gene in patients with Graves' disease. J Endocrinol Invest 25:208-213
143. Nithiyananthan R, Heward JM, Allahabadia A, Franklyn JA, Gough SC 2002 Polymorphism of the CTLA-4 gene is associated with autoimmune hypothyroidism in the United Kingdom. Thyroid 12:3-6
144. Braun J, Donner H, Siegmund T, Walfish PG, Usadel KH, Badenhoop K 1998 CTLA-4 promoter variants in patients with Graves' disease and Hashimoto's thyroiditis. Tissue Antigens 51: 563-566
145. Yanagawa T, Taniyama M, Enomoto S, Gomi K, Maruyama H, Ban Y, Saruta T 1997 CTLA4 gene polymorphism confers susceptibility to Graves' disease in Japanese. Thyroid 7:843-846
146. Akamizu T, Sale MM, Rich SS, Hiratani H, Noh JY, Kanamoto N, Saijo M, Miyamoto Y, Saito Y, Nakao K, Bowden DW 2000 Association of autoimmune thyroid disease with microsatellite markers for the thyrotropin receptor gene and CTLA-4 in Japanese patients. Thyroid 10:851-858
147. Park YJ, Chung HK, Park DJ, Kim WB, Kim SW, Koh JJ, Cho BY 2000 Polymorphism in the promoter and exon 1 of the cytotoxic T lymphocyte antigen-4 gene associated with autoimmune thyroid disease in Koreans. Thyroid 10:453-459
148. Heward JM, Allahabadia A, Armitage M, Hattersley A, Dodson PM, Macleod K, Carr-Smith J, Daykin J, Daly A, Sheppard MC, Holder RL, Barnett AH, Franklyn JA, Gough SC 1999 The development of Graves' disease and the CTLA-4 gene on chromosome 2q33. J Clin Endocrinol Metab 84:2398-2401
149. Heward JM, Allahabadia A, Carr-Smith J, Daykin J, Cockram CS, Gordon CBAH, Franklyn JA, Gough SCL 1998 No evidence for allelic association of human CTLA-4 promoter polymorphism with autoimmune thyroid disease in either population-based case-control or family-based studies. Clin Endocrinol (Oxf) 49:331-334
150. Tomer Y 2001 Unraveling the genetic susceptibility to autoimmune thyroid diseases: CTLA-4 takes the stage. Thyroid 11:167-169
151. Ueda H, Howson JM, Esposito L, Heward J, Snook H, Chamberlain G, Rainbow DB, Hunter KM, Smith AN, Di Genova G, Herr MH, Dahlman I, Payne F, Smyth D, Lowe C, Twells RC, Howlett S, Healy B, Nutland S, Rance HE, Everett V, Smink LJ, Lam AC, Cordell HJ, Walker NM, Bordin C, Hulme J, Motzo C, Cucca F, Hess JF, Metzker ML, Rogers J, Gregory S, Allahabadia A, Nithiyananthan R, Tuomilehto-Wolf E, Tuomilehto J, Bingley P, Gillespie KM, Undlien DE, Ronningen KS, Guja C, Ionescu-Tirgoviste C, Savage DA, Maxwell AP, Carson DJ, Patterson CC, Franklyn JA, Clayton DG, Peterson LB, Wicker LS, Todd JA, Gough SC 2003 Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423:506-511
152. Vaidya B, Imrie H, Geatch DR, Perros P, Ball SG, Baylis PH, Carr D, Hurel SJ, James RA, Kelly WF, Kemp EH, Young ET, Weetman AP, Kendall-Taylor P, Pearce SH 2000 Association analysis of the cytotoxic T lymphocyte antigen-4 (CTLA-4) and autoimmune regulator-1 (AIRE-1) genes in sporadic autoimmune Addison's disease. J Clin Endocrinol Metab 85:688-691
153. Huang D, Liu L, Noren K, Xia SQ, Trifunovic J, Pirskanen R, Lefvert AK 1998 Genetic association of Ctla-4 to myasthenia gravis with thymoma. J Neuroimmunol 88:192-198
154. Donner H, Braun J, Seidl C, Rau H, Finke R, Ventz M, Walfish PG, Usadel KH, Badenhoop K 1997 Codon 17 polymorphism of the cytotoxic T lymphocyte antigen 4 gene in Hashimoto's thyroiditis and Addison's disease. J Clin Endocrinol Metab 82:4130-4132
155. Sale MM, Akamizu T, Howard TD, Yokota T, Nakao K, Mori T, Iwasaki H, Rich SS, Jennings-Gee JE, Yamada M, Bowden DW 1997 Association of autoimmune thyroid disease with a microsatellite marker for the thyrotropin receptor gene and CTLA-4 in a Japanese population. Proc Assoc Am Physicians 109:453-461
156. Petrone A, Giorgi G, Mesturino CA, Capizzi M, Cascino I, Nistico L, Osborn J, Di Mario U, Buzzetti R 2001 Association of DRB1*04- DQB1*0301 haplotype and lack of association of two polymorphic sites at CTLA-4 gene with Hashimoto's thyroiditis in an Italian population. Thyroid 11:171-175
157. Tomer Y, Greenberg DA, Barbesino G, Concepcion ES, Davies TF 2001 CTLA-4 and not CD28 is a susceptibility gene for thyroid autoantibody production. J Clin Endocrinol Metab 86:1687-1693
158. Zaletel K, Krhin B, Gaberscek S, Pirnat E, Hojker S 2002 The influence of the exon 1 polymorphism of the cytotoxic T lymphocyte antigen 4 gene on thyroid antibody production in patients with newly diagnosed Graves' disease. Thyroid 12:373-376
159. Vanderpump MPJ, Tunbridge WMG, French JM, Appleton D, Bates D, Clark F, Grimley Evans J, Hasan DM, Rodgers H, Tunbridge F, Young ET 1995 The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham survey. Clin Endocrinol (Oxf) 43:55-68
160. Kinjo Y, Takasu N, Komiya I, Tomoyose T, Takara M, Kouki T, Shimajiri Y, Yabiku K, Yoshimura H 2002 Remission of Graves' hyperthyroidism and A/G polymorphism at position 49 in exon 1 of cytotoxic T lymphocyte-associated molecule-4 gene. J Clin Endocrinol Metab 87:2593-2596
161. Yung E, Cheng PS, Fok TF, Wong GW 2002 CTLA-4 gene A-G polymorphism and childhood Graves' disease. Clin Endocrinol (Oxf) 56:649-653
162. Allahabadia A, Heward JM, Nithiyananthan R, Gibson SM, Reuser TT, Dodson PM, Franklyn JA, Gough SC 2001 MHC class II region, CTLA4 gene, and ophthalmopathy in patients with Graves' disease. Lancet 358:984-985
163. Vaidya B, Imrie H, Perros P, Dickinson J, McCarthy MI, Kendall-Taylor P, Pearce SH 1999 Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphism confers susceptibility to thyroid associated orbitopathy. Lancet 354:743-744
164. Marron MP, Zeidler A, Raffel LJ, Eckenrode SE, Yang JJ, Hopkins DI, Garchon HJ, Jacob CO, Serrano-Rios M, Martinez Larrad MT, Park Y, Bach JF, Rotter JI, Yang MC, She JX 2000 Genetic and physical mapping of a type 1 diabetes susceptibility gene (IDDM12) to a 100-kb phagemid artificial chromosome clone containing D2S72-CTLA4-D2S105 on chromosome 2q33. Diabetes 49:492-499
165. Wood JP, Pani MA, Bieda K, Meyer G, Usadel KH, Badenhoop K 2002 A recently described polymorphism in the CD28 gene on chromosome 2q33 is not associated with susceptibility to type 1 diabetes. Eur J Immunogenet 29:347-349
166. Davies TF, Martin A, Concepcion ES, Graves P, Cohen L, BenNun A 1991 Evidence of limited variability of antigen receptors on intrathyroidal T cells in autoimmune thyroid disease. N Engl J Med 325:238-244
167. Demaine A, Welsh KI, Hawe BS, Farid NR 1987 Polymorphism of the T cell receptor β-chain in Graves' disease. J Clin Endocrinol Metab 65:643-646
168. Weetman AP, So AK, Roe C, Walport MJ, Foroni L 1987 T-cell receptor α chain V region polymorphism linked to primary autoimmune hypothyroidism but not Graves' disease. Hum Immunol 20:167-173
169. Uno H, Sasazuki H, Tamia H, Matsumoto H 1981 Two major genes, linked to HLA and Gm, control susceptibility to Graves' disease. Nature 292:768-770
170. Nagataki S 1986 The interaction of MHC and Gm in liability to autoimmune thyroid disease. Mol Biol Med 3:73-84
171. Nakao Y, Matsumoto H, Miyazaki T, Nishitani H, Takatsuki K, Kasukawa R, Nakayama S, Izumi S, Fujita T, Tsuji K 1980 IgG heavy chain allotypes (Gm) in atrophic and goitrous thyroiditis. Clin Exp Immunol 42:20-26
172. Roman SH, Hubbard M, Rubinstein P, Failure to confirm standard HLA and Gm immunogenetic typing as a predictor of familial autoimmune thyroid disease. Program of the 71st Annual Meeting of The Endocrine Society, Seattle, WA, 1989 (Abstract)
173. Fakhfakh F, Maalej A, Makni H, Abid M, Jouida J, Zouali M, Ayadi H 1999 Analysis of immunoglobulin VH and TCR cβa polymorphisms in a large family with thyroid autoimmune disorder. Exp Clin Immunogenet 16:185-191
174. Tomer Y, Barbesino G, Keddache M, Greenberg DA, Davies TF 1997 Mapping of a major susceptibility locus for Graves' disease (GD-1) to chromosome 14q31. J Clin Endocrinol Metab 82:1645-1648
175. Blakemore AIF, Watson PF, Weetman AP, Duff GW 1995 Association of Graves' disease with an allele of the interleukin-1 receptor antagonist gene. J Clin Endocrinol Metab 80:111-115
176. Cuddihy RM, Bahn RS 1996 Lack of an association between alleles of interleukin-1 α and interleukin-1 receptor antagonist genes and Graves' disease in a North American Caucasian population. J Clin Endocrinol Metab 81:4476-4478
177. Muhlberg T, Kirchberger M, Spitzweg C, Herrmann F, Heberling HJ, Heufelder AE 1998 Lack of association of Graves' disease with the A2 allele of the interleukin-1 receptor antagonist gene in a white European population. Eur J Endocrinol 138:686-690
178. Heward J, Allahabadia A, Gordon C, Sheppard MC, Barnett AH, Franklyn JA, Gough SC 1999 The interleukin-1 receptor antagonist gene shows no allelic association with three autoimmune diseases. Thyroid 9:627-628
179. Kamizono S, Hiromatsu Y, Seki N, Bednarczuk T, Matsumoto H, Kimura A, Itoh K 2000 A polymorphism of the 5′ flanking region of tumour necrosis factor α gene is associated with thyroid-associated ophthalmopathy in Japanese. Clin Endocrinol (Oxf) 52:759-764
180. Siegmund T, Usadel KH, Donner H, Braun J, Walfish PG, Badenhoop K 1998 Interferon-γ gene microsatellite polymorphisms in patients with Graves' disease. Thyroid 8:1013-1017
181. Rau H, Nicolay A, Usadel KH, Finke R, Donner H, Walfish PG, Badenhoop K 1997 Polymorphisms of TAP1 and TAP2 genes in Graves' disease. Tissue Antigens 49:16-22
182. Heward JM, Nithiyananthan R, Allahabadia A, Gibson S, Franklyn JA, Gough SC 2001 No association of an interleukin 4 gene promoter polymorphism with Graves' disease in the United Kingdom. J Clin Endocrinol Metab 86:3861-3863
183. Ban Y, Taniyama M, Ban Y 2000 Vitamin D receptor gene polymorphism is associated with Graves' disease in the Japanese population. J Clin Endocrinol Metab 85:4639-4643
184. Pani MA, Regulla K, Segni M, Hofmann S, Hufner M, Pasquino AM, Usadel KH, Badenhoop K 2002 A polymorphism within the vitamin D-binding protein gene is associated with Graves' disease but not with Hashimoto's thyroiditis. J Clin Endocrinol Metab 87:2564-2567
185. Tonacchera M, Pinchera A 2000 Thyrotropin receptor polymorphisms and thyroid diseases. J Clin Endocrinol Metab 85:2637-2639
186. Cuddihy RM, Dutton CM, Bahn RS 1995 A polymorphism in the extracellular domain of the thyrotropin receptor is highly associated with autoimmune thyroid disease in females. Thyroid 5:89-95
187. Kotsa KD, Watson PF, Weetman AP 1997 No association between a thyrotropin receptor gene polymorphism and Graves' disease in the female population. Thyroid 7:31-33
188. Allahabadia A, Heward JM, Mijovic C, Carr-Smith J, Daykin J, Cockram C, Barnett AH, Sheppard MC, Franklyn JA, Gough SC 1998 Lack of association between polymorphism of the thyrotropin receptor gene and Graves' disease in United Kingdom and Hong Kong Chinese patients: case control and family-based studies. Thyroid 8:777-780
189. Simanainen J, Kinch A, Westermark K, Winsa B, Bengtsson M, Schuppert F, Westermark B, Heldin NE 1999 Analysis of mutations in exon 1 of the human thyrotropin receptor gene: high frequency of the D36H and P52T polymorphic variants. Thyroid 9:7-11
190. Kaczur V, Takacs M, Szalai C, Falus A, Nagy Z, Berencsi G, Balazs C 2000 Analysis of the genetic variability of the 1st (CCC/ACC, P52T) and the 10th exons (bp 1012-1704) of the TSH receptor gene in Graves' disease. Eur J Immunogenet 27:17-23
191. Chistyakov DA, Savost'anov KV, Turakulov RI, Petunina NA, Trukhina LV, Kudinova AV, Balabolkin MI, Nosikov VV 2000 Complex association analysis of Graves' disease using a set of polymorphic markers. Mol Genet Metab 70:214-218
192. Rapoport B, Chazenbalk GD, Jaume JC, McLachlan SM 1998 The thyrotropin (TSH) receptor: interaction with TSH and autoantibodies. Endocr Rev 19:673-716
193. Tomer Y, Barbesino G, Greenberg DA, Concepcion ES, Davies TF 1999 Mapping the major susceptibility loci for familial Graves' and Hashimoto's diseases: evidence for genetic heterogeneity and gene interactions. J Clin Endocrinol Metab 84:4656-4664
194. De Roux N, Shields DC, Misrahi M, Ratanachaiyavong S, McGregor AM, Milgrom E 1996 Analysis of the thyrotropin receptor as a candidate gene in familial Graves' disease. J Clin Endocrinol Metab 81:3483-3486
195. Chistiakov DA, Savost'anov KV, Turakulov RI, Petunina N, Balabolkin MI, Nosikov VV 2002 Further studies of genetic susceptibility to Graves' disease in a Russian population. Med Sci Monit 8:CR180-CR184
196. Muhlberg T, Herrmann K, Joba W, Kirchberger M, Heberling HJ, Heufelder AE 2000 Lack of association of nonautoimmune hyperfunctioning thyroid disorders and a germline polymorphism of codon 727 of the human thyrotropin receptor in a European Caucasian population. J Clin Endocrinol Metab 85:2640-2643
197. Ban Y, Greenberg DA, Concepcion ES, Tomer Y 2002 A germline single nucleotide polymorphism at the intracellular domain of the human thyrotropin receptor does not have a major effect on the development of Graves' disease. Thyroid 12:1079-1083
198. Pirro MT, De Filippis V, Di Cerbo A, Scillitani A, Liuzzi A, Tassi V 1995 Thyroperoxidase microsatellite polymorphism in thyroid disease. Thyroid 5:461-464
199. Tomer Y 1997 Anti-thyroglobulin autoantibodies in autoimmune thyroid diseases: cross-reactive or pathogenic? Clin Immunol Immunopathol 82:3-11
200. Roitt IM, Campbell PN, Doniach D 1958 The nature of the thyroid autoantibodies present in patients with Hashimoto's thyroiditis (lymphadenoid goitre). Biochem J 69:248-254
201. Ericsson UB, Christensen SB, Thorell J 1985 A high prevalence of thyroglobulin autoantibodies in adults with and without thyroid disease as measured with a sensitive solid-phase immunosorbent radioassay. Clin Immunol Immunopathol 37:154-162
202. Kuppers RC, Bresler HS, Lynne Burek C, Gleason SL, Rose NR 1992 Immunodominant determinants of thyroglobulin associated with autoimmune thyroiditis. In: Bona CA, Kaushik AK, eds. Molecular immunobiology of self-reactivity. New York: Marcel Dekker; 247-284
203. Vladutiu AO, Rose NR 1971 Autoimmune murine thyroiditis: relation to histocompatibiltiy (H-2) type. Science 174:1137-1139
204. Beisel K, David CS, Giraldo AA, Kong Y-CM, Rose NR 1982 Regulation of experimental autoimmune thyroiditis: mapping of susceptibility to the I-A subregion of the mouse H-2. Immunogenetics 15:427-430
205. Kong YM, David CS, Lomo LC, Fuller BE, Motte RW, Giraldo AA 1997 Role of mouse and human class II transgenes in susceptibility to and protection against mouse autoimmune thyroiditis. Immunogenetics 46:312-317
206. Kong YC, McCormick DJ, Wan Q, Motte RW, Fuller BE, Giraldo AA, David CS 1995 Primary hormonogenic sites as conserved autoepitopes on thyroglobulin in murine autoimmune thyroiditis. Secondary role of iodination. J Immunol 155:5847-5854
207. Hutchings PR, Cooke A, Dawe K, Champion BR, Geysen M, Valerio R, Roitt IM 1992 A thyroxine-containing peptide can induce murine experimental autoimmune thyroiditis. J Exp Med 175:869-872
208. Wan Q, Motte RW, McCormick DJ, Fuller BE, Giraldo AA, David CS, Kong YM 1997 Primary hormonogenic sites as conserved autoepitopes on thyroglobulin in murine autoimmune thyroiditis: role of MHC class II. Clin Immunol Immunopathol 85:187-194
209. Texier B, Bedin C, Tang H, Camoin L, Laurent Winter C, Charreire J 1992 Characterization and sequencing of a 40-amino-acid peptide from human thyroglobulin inducing experimental autoimmune thyroiditis. J Immunol 148:3405-3411
210. Chronopoulou E, Carayanniotis G 1992 Identification of a thyroiditogenic sequence within the thyroglobulin molecule. J Immunol 149:1039-1044
211. Allen EM, Appel MC, Braverman LE 1987 Iodine-induced thyroiditis and hypothyroidism in the hemithyroidectomized BB/W rat. Endocrinology 121:481-485
212. Braley-Mullen H, Sharp GC, Medling B, Tang H 1999 Spontaneous autoimmune thyroiditis in NOD.H-2 h4 mice. J Autoimmun 12:157-165
213. Premawardhana LD, Lo SS, Phillips DI, Prentice LM, Rees-Smith B 1994 Variability of serum thyroglobulin levels is determined by a major gene. Clin Endocrinol (Oxf) 41:725-729
214. Tomer Y, Greenberg DA, Concepcion E, Ban Y, Davies TF 2002 Thyroglobulin is a thyroid specific gene for the familial autoimmune thyroid diseases. J Clin Endocrinol Metab 87:404-407
215. Grossman CJ, Roselle GA, Mendenhall CL 1991 Sex steroid regulation of autoimmunity. J Steroid Biochem Mol Biol 40:649-659
216. Ando T, Imaizumi M, Graves PN, Unger P, Davies TF 2002 Intrathyroidal fetal microchimerism in Graves' disease. J Clin Endocrinol Metab 87:3315-3320
217. Paavonen T 1994 Hormonal regulation of immune responses. Ann Med 26:255-258
218. Ansar AS, Penhale WJ, Talal N 1985 Sex hormones, immune responses, and autoimmune diseases. Mechanisms of sex hormone action. Am J Pathol 121:531-551
219. Okayasu I, Kong YM, Rose NR 1981 Effect of castration and sex hormones on experimental autoimmune thyroiditis. Clin Immunol Immunopathol 20:240-245
220. Kanda N, Tamaki K 1999 Estrogen enhances immunoglobulin production by human PBMCs. J Allergy Clin Immunol 103:282-288
221. Ansar AS, Young PR, Penhale WJ 1983 The effects of female sex steroids on the development of autoimmune thyroiditis in thymectomized and irradiated rats. Clin Exp Immunol 54:351-358
222. Kim S, Liva SM, Dalal MA, Verity MA, Voskuhl RR 1999 Estriol ameliorates autoimmune demyelinating disease: implications for multiple sclerosis. Neurology 52:1230-1238
223. de Kerdanet M, Lucas J, Lemee F, Lecornu M 1994 Turner's syndrome with X-isochromosome and Hashimoto's thyroiditis. Clin Endocrinol (Oxf) 41:673-676
224. Ivarsson SA, Ericsson UB, Nilsson KO, Gustafsson J, Hagenas L, Hager A, Moell C, Tuvemo T, Westphal O, Albertsson-Wikland K 1995 Thyroid autoantibodies, Turner's syndrome and growth hormone therapy. Acta Paediatr 84:63-65
225. Medeiros CC, Marini SH, Baptista MT, Guerra Jr G, Maciel-Guerra AT 2000 Turner's syndrome and thyroid disease: a transverse study of pediatric patients in Brazil. J Pediatr Endocrinol Metab 13:357-362
226. Elsheikh M, Wass JA, Conway GS 2001 Autoimmune thyroid syndrome in women with Turner's syndrome-the association with karyotype. Clin Endocrinol (Oxf) 55:223-226
227. Barbesino G, Tomer Y, Concepcion ES, Davies TF, Greenberg D 1998 Linkage analysis of candidate genes in autoimmune thyroid disease. 2. Selected gender-related genes and the X-chromosome. J Clin Endocrinol Metab 83:3290-3295
228. Tomer Y, Ban Y, Concepcion E, Barbesino G, Villanueva R, Greenberg DA, Davies TF, Common and unique susceptibility loci in Graves' and Hashimoto's diseases: results of whole genome screening in a dataset of 102 multiplex multi-generational families. Am J Hum Genet, in press
229. Imrie H, Vaidya B, Perros P, Kelly WF, Toft AD, Young ET, Kendall-Taylor P, Pearce SHS 2001 Evidence for a Graves' disease susceptibility locus at chromosome Xp11 in a United Kingdom population. J Clin Endocrinol Metab 86:626-630
230. Stewart JJ 1998 The female X-inactivation mosaic in systemic lupus erythematosus. Immunol Today 19:352-357
231. Chitnis S, Monteiro J, Glass D, Apatoff B, Salmon J, Concannon P, Gregersen PK 2000 The role of X-chromosome inactivation in female predisposition to autoimmunity. Arthritis Res 2:399-406
232. Weetman AP, Jenkins RC 2002 Disease associations with autoimmune thyroid disease. Thyroid 12:977-988
233. Gray RS, Elton RA, Clarke BF 1983 Familial distribution of thyroid disease and diabetes: further evidence for aetiological heterogeneity of diabetes mellitus. Q J Med 52:244-255
234. Payami H, Joe S, Thomson G 1989 Autoimmune thyroid disease in type 1 diabetes. Genet Epidemiol 6:137-141
235. Torfs CP, King M-C, Bing H, Malmgren J, Grumet FC 1986 Genetic interrelationship between insulin-dependent diabetes mellitus, the autoimmune thyroid diseases, and rheumatoid arthritis. Am J Hum Genet 38:170-187
236. Tomer Y, Greenberg DA, Davies TF 1999 The genetic susceptibility to type 1 (insulin dependent) diabetes mellitus and autoimmune thyroid diseases: from epidemiological observations to gene mapping. In: Volpe R, ed. Contemporary endocrinology: autoimmune endocrinopathies. Totowa, NJ: Humana Press; 57-90
237. Kordonouri O, Klinghammer A, Lang EB, Gruters-Kieslich A, Grabert M, Holl RW 2002 Thyroid autoimmunity in children and adolescents with type 1 diabetes: a multicenter survey. Diabetes Care 25:1346-1350
238. Kordonouri O, Deiss D, Danne T, Dorow A, Bassir C, Gruters-Kieslich A 2002 Predictivity of thyroid autoantibodies for the development of thyroid disorders in children and adolescents with type 1 diabetes. Diabet Med 19:518-521
239. Alvarez-Marfany M, Roman SH, Drexler AJ, Robertson C, Stagnaro-Green A 1994 Long-term prospective study of post-partum thyroid dysfunction in women with insulin dependent diabetes mellitus. J Clin Endocrinol Metab 79:10-16
240. Bech K, Hoier-Madsen M, Feldt-Rasmussen U, Jensen BM, Molsted-Pedersen L, Kuhl C 1991 Thyroid function and autoimmune manifestations in insulin-dependent diabetes mellitus during and after pregnancy. Acta Endocrinol (Copenh) 124:534-539
241. Weetman AP 1994 Insulin-dependent diabetes mellitus and post-partum thyroiditis: an important association. J Clin Endocrinol Metab 79:7-9
242. McCanlies E, O'Leary LA, Foley TP, Kramer MK, Burke JP, Libman A, Swan JS, Steenkiste AR, McCarthy BJ, Trucco M, Dorman JS 1998 Hashimoto's thyroiditis and insulin-dependent diabetes mellitus: differences among individuals with and without abnormal thyroid function. J Clin Endocrinol Metab 83:1548-1551
243. Cox NJ, Wapelhorst B, Morrison VA, Johnson L, Pinchuk L, Spielman RS, Todd JA, Concannon P 2001 Seven regions of the genome show evidence of linkage to type 1 diabetes in a consensus analysis of 767 multiplex families. Am J Hum Genet 69:820-830
244. Luo DF, Bui MM, Muir A, Maclaren NK, Thomson G, She JX 1995 Affected sibpair mapping of a novel susceptibility gene to insulin-dependent diabetes mellitus (IDDM8) on chromosome 6q25-27. Am J Hum Genet 57:911-919
245. Luo DF, Buzzetti R, Rotter JI, Maclaren NK, Raffel LJ, Nistico L, Giovannini C, Pozzilli P, Thomson G, She JX 1996 Confirmation of three susceptibility genes to insulin-dependent diabetes mellitus: IDDM4, IDDM5 and IDDM8. Hum Mol Genet 5:693-698
246. Allahabadia A, Heward J, Carr-Smith J, Daykin J, Barnett AH, Sheppard MC, Franklyn JA, Gough SC 1999 Sharing of susceptibility loci between autoimmune diseases: lack of association of the insulin gene region with Graves' disease. Thyroid 9:317-318
247. Vaidya B, Imrie H, Perros P, Young ET, Kelly WF, Carr D, Large DM, Toft AD, Kendall-Taylor P, Pearce SH 2000 Evidence for a new Graves disease susceptibility locus at chromosome 18q21. Am J Hum Genet 66:1710-1714
248. Tomer Y, Barbesino G, Greenberg DA, Concepcion ES, Davies TF 1998 Linkage analysis of candidate genes in autoimmune thyroid disease. 3. Detailed analysis of chromosome 14 localizes GD-1 close to MNG-1. J Clin Endocrinol Metab 83:4321-4327
249. Biunno I, Appierto V, Cattaneo M, Leone BE, Balzano GP, Socci C, Saccone S, Letizia A, Della Valle G, Sgaramella V1997 Isolation of a pancreas-specific gene located on human chromosome 14q31: expression analysis in human pancreatic ductal carcinomas. Genomics 46:284-286
250. Ban Y, Taniyama M, Tozaki T, Yanagawa T, Tomita M, Ban Y 2001 SEL1L microsatellite polymorphism in Japanese patients with autoimmune thyroid diseases. Thyroid 11:335-338
251. Pearce SH, Vaidya B, Imrie H, Perros P, Kelly WF, Toft AD, McCarthy MI, Young ET, Kendall-Taylor P 1999 Further evidence for a susceptibility locus on chromosome 20q13.11 in families with dominant transmission of Graves disease. Am J Hum Genet 65: 1462-1465
252. Tomer Y, Concepcion E, Greenberg DA 2002 A C/T single nucleotide polymorphism in the region of the CD40 gene is associated with Graves' disease. Thyroid 12:1129-1135
253. Durie FH, Foy TM, Masters SR, Laman JD, Noelle RJ 1994 The role of CD40 in the regulation of humoral and cell-mediated immunity. Immunol Today 15:406-411
254. Banchereau J, Bazan F, Blanchard D, Briere F, Galizzi JP, van Kooten C, Liu YJ, Rousset F, Saeland S 1994 The CD40 antigen and its ligand. Annu Rev Immunol 12:881-922
255. Foy TM, Aruffo A, Bajorath J, Buhlmann JE, Noelle RJ 1996 Immune regulation by CD40 and its ligand GP39. Annu Rev Immunol 14:591-617
256. Carayanniotis G, Masters SR, Noelle RJ 1997 Suppression of murine thyroiditis via blockade of the CD40-CD40L interaction. Immunology 90:421-426
257. Villanueva R, Tomer Y, Greenberg DA, Mao C, Concepcion ES, Tucci S, Estilo G, Davies TF 2002 Autoimmune thyroid disease susceptibility loci in a large Chinese family. Clin Endocrinol (Oxf) 56:45-51
258. Eng C 1996 Seminars in medicine of the Beth Israel Hospital, Boston. The RET proto-oncogene in multiple endocrine neoplasia type 2 and Hirschsprung's disease. N Engl J Med 335:943-951
259. Puxeddu E, Fagin JA 2001 Genetic markers in thyroid neoplasia. Endocrinol Metab Clin North Am 30:493-513
260. Aitman TJ, Todd JA 1995 Molecular genetics of diabetes mellitus. Baillière's Clin Endocrinol Metab 9:631-656
261. Kouki T, Sawai Y, Gardine CA, Fisfalen ME, Alegre ML, DeGroot LJ 2000 CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease. J Immunol 165:6606-6611
262. Xu Y, Graves P, Tomer Y, Davies T 2002 CTLA-4 and autoimmune thyroid disease: lack of influence of the A49G signal peptide polymorphism on functional recombinant human CTLA-4. Cell Immunol 215:133-140
263. Buus S, Sette A, Grey HM 1987 The interaction between protein-derived immunogenic peptides and Ia. Immunol Rev 98:115-141
264. Faas S, Trucco M 1994 The genes influencing the susceptibility to IDDM in humans. J Endocrinol Invest 17:477-495
265. Morel PA, Dorman JS, Todd JA, McDevitt HO, Trucco M 1988 Aspartic acid at position 57 of the HLA-DQ β-chain protects against type I diabetes: a family study. Proc Natl Acad Sci USA 85:8111-8115
266. Brown JH, Jardetzky T, Gorga JC, Stern LJ, Urban RG, Strominger JL, Wiley DC 1993 Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature 364:33-39
267. Lee KH, Wucherpfennig KW, Wiley DC 2001 Structure of a human insulin peptide-HLA-DQ8 complex and susceptibility to type 1 diabetes. Nat Immunol 2:501-507
268. Wucherpfennig KW 2001 Insights into autoimmunity gained from structural analysis of MHC-peptide complexes. Curr Opin Immunol 13:650-656
269. Sawai Y, DeGroot LJ 2000 Binding of human thyrotropin receptor peptides to a Graves' disease-predisposing human leukocyte antigen class II molecule. J Clin Endocrinol Metab 85:1176-1179
270. Hanafusa T, Pujol Borrell R, Chiovato L, Russell RC, Doniach D, Bottazzo GF 1983 Aberrant expression of HLA-DR antigen on thyrocytes in Graves' disease: relevance for autoimmunity. Lancet 2:1111-1115
271. Bottazzo GF, Pujol Borrell R, Hanafusa T, Feldmann M 1983 Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity. Lancet 2:1115-1119
272. Davies TF 1985 Cocultures of human thyroid monolayer cells and autologous T cells: impact of HLA class II antigen expression. J Clin Endocrinol Metab 61:418-422
273. Londei M, Lamb JR, Bottazzo GF, Feldmann M 1984 Epithelial cells expressing aberrant MHC class II determinants can present antigen to cloned human T cells. Nature 312:639-641
274. Tomer Y, Davies TF 2000 The genetics of familial and non-familial hyperthyroid Graves' disease. In: Rapoport B, McLachlan SM, eds. Graves' disease: pathogenesis and treatment. Boston: Kluwer Academic Publishers; 19-41
275. Davies TF, Piccinini LA 1987 Intrathyroidal MHC class II antigen expression and thyroid autoimmunity. Endocrinol Metab Clin North Am 16:247-268
276. Neufeld DS, Platzer M, Davies TF 1989 Reovirus induction of MHC class II antigen in rat thyroid cells. Endocrinology 124: 543-545
277. Belfiore A, Mauerhoff T, Pujol Borrell R, Badenhoop K, Buscema M, Mirakian R, Bottazzo GF 1991 De novo HLA class II and enhanced HLA class I molecule expression in SV40 transfected human thyroid epithelial cells. J Autoimmun 4:397-414
278. Shimojo N, Kohno Y, Yamaguchi K, Kikuoka S, Hoshioka A, Niimi H, Hirai A, Tamura Y, Saito Y, Kohn LD, Tahara K 1996 Induction of Graves-like disease in mice by immunization with fibroblasts transfected with the thyrotropin receptor and a class II molecule. Proc Natl Acad Sci USA 93:11074-11079
279. Kita M, Ahmad L, Marians RC, Vlase H, Unger P, Graves PN, Davies TF 1999 Regulation and transfer of a murine model of thyrotropin receptor antibody mediated Graves' disease. Endocrinology 140:1392-1398
280. Davies TF, Bermas B, Platzer M, Roman SH 1985 T-cell sensitization to autologous thyroid cells and normal non-specific suppressor T-cell function in Graves' disease. Clin-Endocrinol (Oxf) 22:155-167
281. Eguchi K, Otsubo T, Kawabe K, Ueki Y, Fukuda T, Mayumi M, Shimomura C, Ishikawa N, Nakao H, Ito K, Morimoto C, Nagataki S 1987 The remarkable proliferation of helper T cell subset in response to autologous thyrocytes and intrathyroidal T cells from patients with Graves' disease. Isr J Med Sci 70:403-410
282. Migita K, Eguchi K, Otsubo T, Kawakami A, Nakao H, Ueki Y, Shimomura C, Kurata A, Fukuda T, Matsunaga M, Ishikawa N, Ito K, Nagataki S 1990 Cytokine regulation of HLA on thyroid epithelial cells. Clin Exp Immunol 82:548-552
283. Weetman AP, McGregor AM 1994 Autoimmune thyroid disease: further developments in our understanding. Endocr Rev 15: 788-830
284. Huang D, Giscombe R, Zhou Y, Pirskanen R, Lefvert AK 2000 Dinucleotide repeat expansion in the CTLA-4 gene leads to T cell hyper-reactivity via the CD28 pathway in myasthenia gravis. J Neuroimmunol 105:69-77
285. Holopainen PM, Partanen J 2001 Technical note: linkage disequilibrium and disease-associated CTLA-4 gene polymorphisms. J Immunol 167:2457-2458
286. Bagchi N, Brown TR, Urdanivia E, Sundick RS 1985 Induction of autoimmune thyroiditis in chickens by dietary iodine. Science 230: 325-327
287. Kahaly GJ, Dienes HP, Beyer J, Hommel G 1998 Iodide induces thyroid autoimmunity in patients with endemic goitre: a randomised, double-blind, placebo-controlled trial. Eur J Endocrinol 139: 290-297
288. Papanastasiou L, Alevizaki M, Piperingos G, Mantzos E, Tseleni-Balafouta S, Koutras DA 2000 The effect of iodine administration on the development of thyroid autoimmunity in patients with nontoxic goiter. Thyroid 10:493-497
289. dos Remedios LV, Weber PM, Feldman R, Schurr DA, Tsoi TG 1980 Detecting unsuspected thyroid dysfunction by the free thyroxine index. Arch Intern Med 140:1045-1049
290. Stenszky V, Kozma L, Balazs C, Rochkitz S, Bear JC, Farid NR 1985 The genetics of Graves' disease: HLA and disease susceptibility. J Clin Endocrinol Metab 61:735-740
291. Frecker M, Mercer G, Skanes VM, Farid NR 1988 Major histocompatibility complex (MHC) factors predisposing to and protecting against Graves' eye disease. Autoimmunity 1:307-315
292. McGregor A, Rees Smith B, Hall R, Petersen M, Miller M, Dewar P 1980 Prediction of relapse in hyperthyroid Graves' disease. Lancet I:1101-1103
293. Weetman AP, So AK, Warner CA, Foroni L, Fells P, Shine B 1988 Immunogenetics of Graves' ophthalmopathy. Clin Endocrinol (Oxf) 28:619-628
294. Chen QY, Huang W, She JX, Baxter F, Volpe R, Maclaren NK 1999 HLA-DRB1*08, DRB1*03/DRB3*0101, and DRB3*0202 are susceptibility genes for Graves' disease in North American Caucasians, whereas DRB1*07 is protective. J Clin Endocrinol Metab 84:3182-3186
295. Hawkins BR, Ma JT, Lam KS, Wang CC, Yeung RT 1985 Association of HLA antigens with thyrotoxic Graves' disease and periodic paralysis in Hong Kong Chinese. Clin Endocrinol (Oxf) 23: 245-252
296. Wong GWK, Cheng SH, Dorman JS 1999 The HLA-DQ associations with Graves' disease in Chinese children. Clin Endocrinol (Oxf) 50:493-495
297. Sasazuki T, Nishimura Y, Muto M, Ohta N 1983 HLA-linked genes controlling immune response and disease susceptibility. Immunol Rev 70:51-75
298. Dong RP, Kimura A, Okubo R, Shinagawa H, Tamai H, Nishimura Y, Sasazuki T 1992 HLA-A and DPB1 loci confer susceptibility to Graves' disease. Hum Immunol 35:165-172
299. Cho BY, Rhee BD, Lee DS, Lee MS, Kim GY, Lee HK, Koh CS, Min HK, Lee M 1987 HLA and Graves' disease in Koreans. Tissue Antigens 30:119-121
300. Tandon N, Mehra NK, Taneja V, Vaidya MC, Kochupillai N 1990 HLA antigens in Asian Indian patients with Graves' disease. Clin Endocrinol (Oxf) 33:21-26
301. Sridama V, Hara Y, Fauchet R, DeGroot LJ 1987 HLA immunogenetic heterogeneity in Black American patients with Graves' disease. Arch Intern Med 147:229-231
302. Chen QY, Nadell D, Zhang XY, Kukreja A, Huang YJ, Wise J, Svec F, Richards R, Friday KE, Vargas A, Gomez R, Chalew S, Lan MS, Tomer Y, Maclaren NK 2000 The human leukocyte antigen HLA DRB3*020/DQA1*0501 haplotype is associated with Graves' disease in African Americans. J Clin Endocrinol Metab 85:1545-1549
303. Omar MA, Hammond MG, Desai RK, Motala AA, Aboo N, Seedat MA 1990 HLA class I and II antigens in South African blacks with Graves' disease. Clin Immunol Immunopathol 54:98-102
304. Allen EM, Hsueh WC, Sabra MM, Pollin TI, Ladenson PW, Silver KD, Mitchell BD, Shuldiner AR 2003 A genome-wide scan for autoimmune thyroiditis in the Old Order Amish: replication of genetic linkage on chromosome 5q11.2-q14.3 J Clin Endocrinol Metab 88:1292-1296
305. Bogner U, Badenhoop K, Peters H, Schmieg D, Mayr WR, Usadel KH, Schleusener H 1992 HLA-DR/DQ gene variation in non-goitrous autoimmune thyroiditis at the serological and molecular level. Autoimmunity 14:155-158
306. Ito M, Tanimoto M, Kamura H, Yoneda M, Morishima Y, Yamauchi K, Itatsu T, Takatsuki K, Saito H 1989 Association of HLA antigen and restriction fragment length polymorphism of T cell receptor β-chain gene with Graves' disease and Hashimoto's thyroiditis. J Clin Endocrinol Metab 69:100-104
307. Alkhateeb A, Stetler GL, Old W, Talbert J, Uhlhorn C, Taylor M, Fox A, Miller C, Dills DG, Ridgway EC, Bennett DC, Fain PR, Spritz RA 2002 Mapping of an autoimmunity susceptibility locus (AIS1) to chromosome 1p31.3-p32.2. Hum Mol Genet 11:661-667
308. Tomer Y, Davies TF 2002 Genetic factors relating to the thyroid with emphasis on complex diseases. In: Waas JAH, Shalet SM, eds. Oxford textbook of endocrinology and diabetes. Oxford, UK: Oxford University Press; 358